Patents by Inventor Morgan Watson

Morgan Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-17A inhibitors
    Patent number: 12252491
    Abstract: The invention provides certain difluorocyclohexyl-imidazopyridazinyl-imidazolidinone compounds of formula II as IL-17A inhibitors, pharmaceutical compositions thereof, and methods of using a compound of formula II to treat certain symptoms of psoriasis, rheumatoid arthritis or multiple sclerosis.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: March 18, 2025
    Assignee: ELI LILLY AND COMPANY
    Inventors: David Andrew Coates, Kwame Frimpong, William Glen Holloway, Brian Spencer Jones, Adam Marc Levinson, Charles Willis Lugar, III, Michael Enrico Richett, Brian Morgan Watson, Michael Edward Woodman
  • SYSTEM, METHOD, AND APPARATUS FOR AMELIORATING DEPOSITS IN SELECTIVE CATALYTIC REDUCTION SYSTEMS FOR THE REDUCTION OF NITROGEN OXIDE EMISSIONS IN STEAM METHANE REFORMERS
    Publication number: 20240390834
    Abstract: A system, method, and apparatus for ameliorating deposits in selective catalytic reduction systems for the reduction of nitrogen oxide emissions in steam methane reformers. The system includes positioning a dual stage refractory particulate (RP) filter placed in an upstream airflow from a Selective Catalytic Reduction System (SCRS). The first stage is formed of a perforated steel plate with a second stage formed of a wire mesh screen. The system may employ air cannons to clean each of the first stage and the second stages.
    Type: Application
    Filed: August 1, 2024
    Publication date: November 28, 2024
    Applicant: Integrated Global Services Inc.
    Inventors: Jefferson Landers Shelton, Mark Braithwaite, JR., Jan Albert Schutte, Morgan Watson
  • System, method, and apparatus for ameliorating deposits in selective catalytic reduction systems for the reduction of nitrogen oxide emissions in steam methane reformers
    Patent number: 12076683
    Abstract: A system, method, and apparatus for ameliorating deposits in selective catalytic reduction systems for the reduction of nitrogen oxide emissions in steam methane reformers. The system includes positioning a dual stage refractory particulate (RP) filter placed in an upstream airflow from a Selective Catalytic Reduction System (SCRS). The first stage is formed of a perforated steel plate with a second stage formed of a wire mesh screen. The system may employ air cannons to clean each of the first stage and the second stages.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: September 3, 2024
    Assignee: Integrated Global Services Inc.
    Inventors: Jefferson Landers Shelton, Mark Braithwaite, Jr., Jan Albert Schutte, Morgan Watson
  • GIP/GLP1 CO-AGONIST COMPOUNDS
    Publication number: 20230265151
    Abstract: The present invention relates to compounds having activity at both the human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The present invention also relates to compounds having an extended duration of action at each of these receptors. Furthermore, the present invention relates to compounds that may be administered orally. These compounds may be useful in the treatment of type 2 diabetes mellitus (“T2DM”). These compounds may be useful in the treatment of obesity.
    Type: Application
    Filed: January 21, 2021
    Publication date: August 24, 2023
    Inventors: Jorge ALSINA-FERNANDEZ, Robert Andrew BROWN, Robert Chadwick CUMMINS, Mohamed Elsayed Hamed ELSAYED, Andrea Renee GEISER, Xianyin LAI, Hongchang QU, Brian Morgan WATSON
  • AHR AGONISTS
    Publication number: 20230159493
    Abstract: The present invention relates to certain substituted AHR agonist compounds, to pharmaceutical compositions comprising the compounds and to methods of using the compounds to treat immune-mediated diseases.
    Type: Application
    Filed: September 13, 2022
    Publication date: May 25, 2023
    Inventors: Lacie Marie CHAUVIGNE-HINES, Christian Alexander CLARKE, Douglas Linn GERNERT, Steven James GREEN, Brian Morgan WATSON
  • IL-17A INHIBITORS
    Publication number: 20220073526
    Abstract: The invention provides certain difluorocyclohexyl-imidazopyridazinyl-imidazolidinone compounds of formula II as IL-17A inhibitors, pharmaceutical compositions thereof, and methods of using a compound of formula II to treat certain symptoms of psoriasis, rheumatoid arthritis or multiple sclerosis.
    Type: Application
    Filed: January 3, 2020
    Publication date: March 10, 2022
    Inventors: David Andrew Coates, Kwame Frimpong, William Glen Holloway, Brian Spencer Jones, Adam Marc Levinson, Charles Willis Lugar, III, Michael Enrico Richett, Brian Morgan Watson, Michael Edward Woodman
  • SYSTEM, METHOD, AND APPARATUS FOR CLEANING INDUSTRIAL FURNACES AND ASSOCIATED STRUCTURES
    Publication number: 20210341226
    Abstract: System, method, and apparatus for cleaning industrial furnaces and associated structures. The system improves the dynamic pressure and cleaning of conventional air cannon systems utilizing air as a pressurized gas source for discharge by the air cannon. According to the present invention, the pressurized gas source is selected to have a density greater than air at an equivalent temperature. The increased density of the pressurized gas source improves the cleaning capability of the conventional air cannon for removing stubborn deposits.
    Type: Application
    Filed: April 30, 2021
    Publication date: November 4, 2021
    Applicant: Integrated Global Services Inc.
    Inventors: Jefferson Landers Shelton, Mark Braithwaite, JR., Morgan Watson, Chris Landers, Connor Berry Shelton, Andrew Kline
  • SYSTEM, METHOD, AND APPARATUS FOR AMELIORATING DEPOSITS IN SELECTIVE CATALYTIC REDUCTION SYSTEMS FOR THE REDUCTION OF NITROGEN OXIDE EMISSIONS IN STEAM METHANE REFORMERS
    Publication number: 20210322911
    Abstract: A system, method, and apparatus for ameliorating deposits in selective catalytic reduction systems for the reduction of nitrogen oxide emissions in steam methane reformers. The system includes positioning a dual stage refractory particulate (RP) filter placed in an upstream airflow from a Selective Catalytic Reduction System (SCRS). The first stage is formed of a perforated steel plate with a second stage formed of a wire mesh screen. The system may employ air cannons to clean each of the first stage and the second stages.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 21, 2021
    Applicant: Integrated Global Services Inc.
    Inventors: Jefferson Landers Shelton, Mark Braithwaite, JR., Jan Albert Schutte, Morgan Watson
  • 5'-SUBSTITUTED NUCLEOSIDE COMPOUNDS
    Publication number: 20160326208
    Abstract: The present invention relates to novel 5?-substituted nucleoside compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, more particularly for the treatment of cancer, in particular glioblastomas, melanoma, sarcomas, gastric cancer, pancreatic cancer, cholangiocarcinoma, bladder cancer, breast cancer, non-small cell lung cancer, leukemias including acute myeloid leukemia, and lymphomas.
    Type: Application
    Filed: April 27, 2016
    Publication date: November 10, 2016
    Inventors: Guillermo S CORTEZ, Karl Robert DAHNKE, Michael John GROGAN, Antonio Rodriguez HERGUETA, James Andrew JAMISON, Brian Morgan WATSON, Timothy Andrew WOODS, Zahid Quyoom BONDAY
  • BACE inhibitors
    Patent number: 9169271
    Abstract: The present invention provides a compound of Formula III: wherein A is: and Z, R1, R2, R3, and R4 are as defined herein, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: October 27, 2015
    Assignee: Eli Lilly and Company
    Inventors: Steven James Green, Erik James Hembre, Dustin James Mergott, Yuan Shi, Brian Morgan Watson, Leonard Larry Winneroski, Jr.
  • BACE INHIBITORS
    Publication number: 20150210716
    Abstract: The present invention provides a compound of Formula III: wherein A is: and Z, R1, R2, R3, and R4 are as defined herein, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 2, 2015
    Publication date: July 30, 2015
    Inventors: Steven James GREEN, Erik James HEMBRE, Dustin James MERGOTT, Yuan SHI, Brian Morgan WATSON, Leonard Larry WINNEROSKI, JR.
  • TETRAHYDROPYRROLOTHIAZINE COMPOUNDS
    Publication number: 20150157641
    Abstract: The present invention provides a compound of Formula I: wherein R is H or F; and A is: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 19, 2015
    Publication date: June 11, 2015
    Inventors: Steven James GREEN, Dustin James MERGOTT, Brian Morgan WATSON, Leonard Larry WINNEROSKI, JR.
  • BACE inhibitors
    Patent number: 9029367
    Abstract: The present invention provides a compound of Formula III: Formula III wherein A is: and Z, R1, R2, R3, and R4 are as defined herein, or a pharmaceutically acceptable salt thereof, which is useful for treating Alzheimer's disease.
    Type: Grant
    Filed: June 11, 2014
    Date of Patent: May 12, 2015
    Assignee: Eli Lilly and Company
    Inventors: Steven James Green, Erik James Hembre, Dustin James Mergott, Yuan Shi, Brian Morgan Watson, Leonard Larry Winneroski, Jr.
  • Tetrahydropyrrolothiazine compounds
    Patent number: 8987254
    Abstract: The present invention provides a compound of Formula I: wherein R is H or F; and A is: or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: March 24, 2015
    Assignee: Eli Lilly and Company
    Inventors: Steven James Green, Dustin James Mergott, Brian Morgan Watson, Leonard Larry Winneroski, Jr.
  • BACE INHIBITORS
    Publication number: 20140371212
    Abstract: The present invention provides a compound of Formula III: wherein A is: and Z, R1, R2, R3, and R4 are as defined herein, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 11, 2014
    Publication date: December 18, 2014
    Inventors: Steven James GREEN, Erik James HEMBRE, Dustin James MERGOTT, Yuan SHI, Brian Morgan WATSON, Leonard Larry WINNEROSKI, JR.
  • TETRAHYDROPYRROLOTHIAZINE COMPOUNDS
    Publication number: 20140350245
    Abstract: The present invention provides a compound of Formula I: wherein R is H or F; and A is: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 7, 2014
    Publication date: November 27, 2014
    Inventors: Steven James GREEN, Dustin James MERGOTT, Brian Morgan WATSON, Leonard Larry WINNEROSKI, JR.
  • Tetrahydropyrrolothiazine compounds
    Patent number: 8889856
    Abstract: The present invention provides compounds of Formula I: wherein A is selected from the group consisting of; R1 is H or F; R2 is H, —CH2OH, C1-C3 alkyl, R3 is H, F, or CN; R4 is H, F; or CN; and R5 is H, —CH3, or —OCH3; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: November 18, 2014
    Assignee: Eli Lilly and Company
    Inventors: James Peter Beck, Steven James Green, Jose Eduardo Lopez, Brian Michael Mathes, Dustin James Mergott, Warren Jaye Porter, Zoran Rankovic, Yuan Shi, Brian Morgan Watson, Leonard Larry Winneroski, Jr.
  • Tetrahydropyrrolothiazine compounds
    Patent number: 8841293
    Abstract: The present invention provides a compound of Formula I: Formula I wherein R is H or F; and A is: or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: September 23, 2014
    Assignee: Eli Lilly and Company
    Inventors: Steven James Green, Dustin James Mergott, Brian Morgan Watson, Leonard Larry Winneroski, Jr.
  • TETRAHYDROPYRROLOTHIAZINE COMPOUNDS
    Publication number: 20140275044
    Abstract: The present invention provides a compound of Formula I: wherein R is H or F; and A is: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 4, 2014
    Publication date: September 18, 2014
    Applicant: Eli Lilly and Company
    Inventors: Steven James GREEN, Dustin James MERGOTT, Brian Morgan WATSON, Leonard Larry WINNEROSKI, JR.
  • TETRAHYDROPYRROLOTHIAZINE COMPOUNDS
    Publication number: 20140256933
    Abstract: The present invention provides compounds of Formula I: wherein A is selected from the group consisting of; R1 is H or F; R2 is H, —CH2OH, C1-C3 alkyl, R3 is H, F, or CN; R4 is H, F; or CN; and R5 is H, —CH3, or —OCH3; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 22, 2014
    Publication date: September 11, 2014
    Applicant: Eli Lilly and Company
    Inventors: James Peter BECK, Steven James GREEN, Jose Eduardo LOPEZ, Brian Michael MATHES, Dustin James MERGOTT, Warren Jaye PORTER, Zoran RANKOVIC, Yuan SHI, Brian Morgan WATSON, Leonard Larry WINNEROSKI, JR.